Browse > Article
http://dx.doi.org/10.22246/jikm.2020.41.6.1274

A Case Report of Symptom Improvement in Stage IV Metastatic Colorectal Cancer Treated with a Korean Medicine-based Integrative Cancer Treatment  

Kim, Jong-hee (East West Cancer Center, Seoul Korean Medicine Hospital of Daejeon University)
Park, Ji-hye (East West Cancer Center, Seoul Korean Medicine Hospital of Daejeon University)
Oh, Hyeon-muk (East West Cancer Center, Daejeon Korean Medicine Hospital of Daejeon University)
Park, So-jung (East West Cancer Center, Daejeon Korean Medicine Hospital of Daejeon University)
Yoo, Hwa-seung (East West Cancer Center, Seoul Korean Medicine Hospital of Daejeon University)
Publication Information
The Journal of Internal Korean Medicine / v.41, no.6, 2020 , pp. 1274-1281 More about this Journal
Abstract
Objective: This case report shows symptom improvements in stage IV metastatic colorectal cancer treated with a Korean medicine-based integrative cancer treatment (ICT). Methods: A 61-year-old male patient diagnosed with colorectal cancer in November 2017 and metastasis to the lung, peritoneum, and liver in September 2020 was treated with Integrative Cancer Treatment (ICT) for abdominal pain, abdominal discomfort, and anorexia for 1 month. Clinical outcomes were measured with the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), a numeral rating (NRS), the Eastern Cooperative Oncology Group (ECOG), and the Functional Assessment of Cancer Therapy-General (FACT-G) scales. Results: After treatment, the patient's abdominal pain was improved from NRS 8 to 1, and the ECOG score of the patient was improved from grade 3 to 2. Integrative Cancer Treatment. Also the score improved on the FACT-G test, and there were no serious side effects of grade 3 or higher according to the NCI-CTCAE. Conclusion: This case study suggests that Korean medicine-based ICT may help to improve abdominal pain and quality of life in patients with metastatic colorectal cancer.
Keywords
colorectal cancer; lung metastasis; abdominal pain; Korean medicine; integrative cancer treatment; quality of life;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Won YJ. Annual report of cancer statistics in Korea in 2017. The Korea Central Cancer Registry, National Cancer Center. Ministry of Health and Welfare; 2019.
2 Ismaili N. Treatment of colorectal liver metastases. World J Surg Oncol 2011;9(1):154.   DOI
3 Leung U, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, et al. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. Ann Surg 2017;265(1):158-65.   DOI
4 McCulloch M, Ly H, Broffman M, See C, Clemons J, Chang R. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials. Integr Cancer Ther 2016;15(3):285-307.   DOI
5 Zhai XF, Liu XL, Shen F, Fan J, Ling CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer 2018;124(10):2161-8.   DOI
6 Kim JM. Integrated Cancer Treatment Roadmap. 1st edition. Goyang: Seohyeonsa; 2014, p. 50, 115, 47.
7 Karlsen S, Addington-Hall J. How do cancer patients who die at home differ from those who die elsewhere? J Palliat Med 1998;12(4):279-86.   DOI
8 Fiorentini G, Sarti D, Casadei V, Milandri C, Dentico P, Mambrini A, et al. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients. Integr Cancer Ther 2019;18:1534735419878505.
9 Ha SJ, Park JH, Park SJ, Lee YW, Cho CK, Yoo HS. A Case Report of Symptom Improvement after lobectomy in Male Breast Cancer with Lung Metastasis Patient Treated with Korean Medicine based Integrative Cancer Treatment. J Korean Tradit Oncol 2020;25(1):1-9.   DOI
10 Vinceti M, Filippini T, Giovane CD, Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2018;1(1):CD005195.
11 Gwak MD, Suh SY. The assessment tools in palliative medicine. Korean J Hosp Palliat Care 2009;12(4):177-93.   DOI
12 The FACIT Measurement System. Available from:URL:http://www.FACIT.org
13 National Cancer institute Common Terminology Criteria for Adverse Events, Version 5.0, revised March, 2018. Avaliable from:URL:https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm
14 Kim DH, Risk Factors of Colorectal Cancer. J Korean Soc Coloproctology 2009;25(5):356-62.   DOI
15 Park HM, Ha NS. Factors Influencing Quality of Life in Colorectal Cancer Patients with ostomy. Clin Nurs Res 2006;12(2):123-4.   DOI
16 Yoo HS, Lee YW, Song KC, Choi BL, Seo SH, Cho JH, et al. The effects of Hangam-dan on anti-metastasis and preventing relapses, administered to 69 cancer patients. J Int Korean Med 2002;23(2):165-73.
17 Kim HG, Han JM, Lee HW, Lee JS, Son SW, Choi MK, et al. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model. J Ethnopharmacol 2013;145(2):653-62.   DOI
18 Rim SY, Oh ST. The Effect of subcutaneous injection of Mistletoe extract for the treatment of chronic pelvic pain. Obstet Gynecol Sci 2005;48(5):1288-93.
19 Hu XP, Shin JW, Wang JH, Cho JH, Son JY, Cho CK, et al. Antioxidative and hepatoprotective effect of CGX, an herbal medicine, against toxic acute injury in mice. J Ethnopharmacol 2008;120(1):51-5.   DOI